Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
Clinical trial NCT04966871 · COMPLETED
Trial details
- NCT number
- NCT04966871
- Sponsor
- Sanaria Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2022-06-21
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.